DK128291D0 - Behandling af iodmangelsygdomme - Google Patents

Behandling af iodmangelsygdomme

Info

Publication number
DK128291D0
DK128291D0 DK911282A DK128291A DK128291D0 DK 128291 D0 DK128291 D0 DK 128291D0 DK 911282 A DK911282 A DK 911282A DK 128291 A DK128291 A DK 128291A DK 128291 D0 DK128291 D0 DK 128291D0
Authority
DK
Denmark
Prior art keywords
iodine
treatment
composition
ild
defects
Prior art date
Application number
DK911282A
Other languages
English (en)
Other versions
DK128291A (da
Inventor
William R Ghent
Bernard A Eskin
Original Assignee
William R Ghent
Bernard A Eskin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by William R Ghent, Bernard A Eskin filed Critical William R Ghent
Publication of DK128291D0 publication Critical patent/DK128291D0/da
Publication of DK128291A publication Critical patent/DK128291A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DK128291A 1989-01-03 1991-07-01 Behandling af iodmangelsygdomme DK128291A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/292,968 US5171582A (en) 1985-07-31 1989-01-03 Treatment of iodine deficiency diseases
PCT/CA1990/000007 WO1990007339A1 (en) 1989-01-03 1990-01-03 Treatment of iodine deficiency diseases

Publications (2)

Publication Number Publication Date
DK128291D0 true DK128291D0 (da) 1991-07-01
DK128291A DK128291A (da) 1991-08-21

Family

ID=23127029

Family Applications (1)

Application Number Title Priority Date Filing Date
DK128291A DK128291A (da) 1989-01-03 1991-07-01 Behandling af iodmangelsygdomme

Country Status (14)

Country Link
US (1) US5171582A (da)
EP (1) EP0377266B1 (da)
JP (1) JP2994741B2 (da)
AT (1) ATE106738T1 (da)
AU (1) AU639222B2 (da)
BG (1) BG94738A (da)
BR (1) BR9006990A (da)
CA (1) CA1336889C (da)
DE (1) DE68915987T2 (da)
DK (1) DK128291A (da)
ES (1) ES2057098T3 (da)
HU (1) HUT57050A (da)
MC (1) MC2172A1 (da)
WO (1) WO1990007339A1 (da)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5589198A (en) * 1985-07-31 1996-12-31 943038 Ontario, Inc. Treatment of iodine deficiency diseases
US6019970A (en) * 1985-07-31 2000-02-01 Ghent William R. Treatment of iodine deficiency diseases
US5250304A (en) * 1985-07-31 1993-10-05 Ghent William R Treatment of iodine deficiency diseases
US5955101A (en) * 1991-03-28 1999-09-21 943038 Ontario Inc. Dry starch-iodine pharmaceutical formulations
ES2114934T3 (es) * 1991-03-28 1998-06-16 Ontario Inc 943038 Formulaciones farmaceuticas secas a base de almidon/yodo.
US5910318A (en) * 1991-03-28 1999-06-08 943038 Ontario Inc. Treatment of iodine deficiency diseases
EP0722727A1 (en) * 1995-01-20 1996-07-24 Eli Lilly And Company Benzofuran derivatives for inhibiting uterine fibroid disease
US5554600A (en) * 1995-01-20 1996-09-10 Eli Lilly And Company Methods for inhibiting endometriosis
US5489587A (en) * 1995-01-20 1996-02-06 Eli Lilly And Company Benzofurans used to inhibit bone loss
US6238644B1 (en) 1997-09-03 2001-05-29 Wayne State University Method for treating and/or imaging breast cancer using radioactive iodide
US5885592A (en) * 1997-10-29 1999-03-23 Symbollon Corporation Methods and pharmaceutical compositions for oral delivery of molecular iodine
US20090214434A1 (en) * 2004-08-20 2009-08-27 O'dowd Dennis Hardy Method of detecting and treating allogenic cells responsible for endometriosis
US9511151B2 (en) 2010-11-12 2016-12-06 Uti Limited Partnership Compositions and methods for the prevention and treatment of cancer
US10988516B2 (en) 2012-03-26 2021-04-27 Uti Limited Partnership Methods and compositions for treating inflammation
US9603948B2 (en) 2012-10-11 2017-03-28 Uti Limited Partnership Methods and compositions for treating multiple sclerosis and related disorders
SG10201912301XA (en) 2013-11-04 2020-02-27 Uti Lp Methods and compositions for sustained immunotherapy
US12011480B2 (en) 2015-05-06 2024-06-18 Uti Limited Partnership Nanoparticle compositions for sustained therapy

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4384960A (en) * 1979-11-13 1983-05-24 Polley R D Iodine dispenser and method of dispensing iodine
US4816255A (en) * 1985-07-31 1989-03-28 Ghent William R Treatment of iodine deficiency breast syndrome
FR2611733B1 (fr) * 1987-02-26 1989-06-16 Rhone Poulenc Chimie Composition a base de gomme diorganopolysiloxane contenant de l'iode pour le traitement des eaux

Also Published As

Publication number Publication date
WO1990007339A1 (en) 1990-07-12
DK128291A (da) 1991-08-21
DE68915987T2 (de) 1995-01-12
BR9006990A (pt) 1991-11-12
AU4819990A (en) 1990-08-01
DE68915987D1 (de) 1994-07-14
JPH04503949A (ja) 1992-07-16
CA1336889C (en) 1995-09-05
US5171582A (en) 1992-12-15
EP0377266A1 (en) 1990-07-11
JP2994741B2 (ja) 1999-12-27
ATE106738T1 (de) 1994-06-15
AU639222B2 (en) 1993-07-22
ES2057098T3 (es) 1994-10-16
BG94738A (bg) 1993-12-24
EP0377266B1 (en) 1994-06-08
HUT57050A (en) 1991-11-28
HU900916D0 (en) 1991-10-28
MC2172A1 (fr) 1992-05-22

Similar Documents

Publication Publication Date Title
DK128291A (da) Behandling af iodmangelsygdomme
ES2061491T3 (es) Procedimiento para preparar cemento dental radioopaco de policarboxilato reticulado.
FR2593823B1 (fr) Compositions acides pseudoplastiques utilisables pour le nettoyage des surfaces
HK1033907A1 (en) Metal chelators for use in the treatment of alzheimer's disease.
MX171177B (es) Composicion para desinfectar sustratos
DK1200418T3 (da) Nematodicide trifluorbutener
PL241175A1 (en) Process for preparing novel quaternary 6,11-dihydro-dibenzo-/b,e/-thiepine-11-n-alkylnorskopinethers
DK505983A (da) Imidazolylalkylthienyl-tetrahydropyridaziner og fremgangsmaade til fremstilling deraf
DK108083D0 (da) Dipeptidsoedemiddel-metal-kompleks og dets anvendelse
SE8005580L (sv) Harvextkomposition och forfarande for dess framstellning
FR2442250A1 (fr) Compositions de verre et ciments auxquels sont incorporees ces compositions
NO166532C (no) Fremgangsmaate for fremstilling av peptidet h-arg-x-z-y-tyr-r.
PL329413A1 (en) Chemical compounds exhibiting properties capable to cause growth hormone release
DE59108033D1 (de) Verwendung eines mikrobioziden Mittels bei der Herstellung von Betondachsteinen
ES8304919A1 (es) Un procedimiento para la preparacion de dicloroamino-acidos.
GR960300006T1 (en) Alkaloids from mappia foetida, the use thereof and formulations containing them.
GB9302046D0 (en) Antiumoral compound-v
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
JPS57169472A (en) Novel soluble n2 substituted derivative of 2,4-diamino-5-benzylpyrimidine, manufacture and drug containing same
NO912528L (no) Behandling av sykdommer forbundet med jodmangel.
SE8903564D0 (sv) New use condensed quinoline compound
ATE111973T1 (de) Metallschützende zusammensetzungen, ihr herstellungsverfahren und metallschutzverfahren.
SE7712281L (sv) Forfarande for framstellning av trankilliseringsmedel
EP0036991B1 (en) 5-alkyl-3-alkylthiopropionthioates, process for their preparation and their use as pharmaceutical compositions
MD421C2 (ro) Derivaţi ai aminoacizilor şi sărurile acido-aditive ale acestora

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment